# US 2012/0252062 A1 · Method for diagnosing and/or predicting the development of neurodegenerative diseases

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0252062 A1
- Document ID: US20120252062A1
- Status: Published application
- Kind: A1
- Application number: 13/416,203
- Filed: 2012-03-09
- Published: 2012-10-04
- Earliest claimed: 2009-09-11
- Assignees: Eberhard-Karls-Universitat Tubingen Universitatsklinikum
- Inventors: Saskia Biskup; Natalja Funk
- Web page: https://patentgrep.com/patent/US20120252062A1

## CPC

- G01N 33/5091: {for testing the pathological state of an organism}
- G01N 33/5094: {for blood cell populations (red blood cells G01N33/80)}
- G01N 2800/28: Neurological disorders
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The present invention relates to a method for diagnosing and/or predicting the development of neurodegenerative diseases; in the method, white blood cells are isolated and enriched or cultivated for forming colony-forming units, wherein CFU-M and other CFU are formed. Subsequently, the relative number of CFU-M formed in the previous cultivation(/enrichment step relative to the other CFUs formed are determined.

## Claims

### Claim 1

A method for diagnosing and/or predicting the development of neurodegenerative diseases, wherein the method has the following steps:
a) isolation of white blood cells from a blood sample from a person to be investigated;
b) enrichment and/or cultivation of the white blood cells isolated in step a) for forming various colony-forming units (CFUs), wherein CFU-M and other CFUs are formed, and
c) determination and evaluation of the relative number of CFU-M formed in step b) relative to the other CFUs formed.

### Claim 2 (depends on 1)

The method as claimed in claim 1, wherein step b) is carried out in a medium for forming various colony-forming units (CFUs).

### Claim 3 (depends on 1)

The method as claimed in claim 1, wherein in step c) the relative number of at least two of the following CFUs formed in step b) is determined and compared, namely CFU-G (CFU-granulocyte) and CFU-M (CFU-macrophage).

### Claim 4 (depends on 3)

The method as claimed in claim 3, wherein additionally the relative number of CFU-GM (CFU-granulocyte/macrophage) is determined.

### Claim 5 (depends on 1)

The method as claimed in claim 1, wherein the determination of a relative number of CFU-M that is higher than the relative number of CFU-G is associated with the presence and/or the course and/or the severity and/or the prediction of neurodegenerative diseases.

### Claim 6 (depends on 1)

The method as claimed in claim 1, wherein in step c) a certain relative number of CFU-M is associated with the presence and/or the course and/or the severity and/or the prediction of neurodegenerative diseases.

### Claim 7 (depends on 6)

The method as claimed in claim 6, wherein a number of CFU-M colonies of at least approx. 25% is associated with the presence and/or course and/or the severity and/or the prediction of neurodegenerative diseases.

### Claim 8 (depends on 1)

The method as claimed in claim 1, wherein the medium used in step b) for culture contains methylcellulose.

### Claim 9 (depends on 1)

The method as claimed in claim 1, wherein the white blood cells are isolated from the blood sample by density-gradient centrifugation or by purification by means of specific antibodies.

### Claim 10 (depends on 1)

The method as claimed claim 1, wherein the white blood cells isolated are cultured for a period of at least 10 days, preferably 14 days.

### Claim 11

A method for diagnosing and/or predicting the development of neurodegenerative diseases, wherein the method comprises the step of employing a CFC assay.

### Claim 12

A method for diagnosing and/or predicting the development of neurodegenerative diseases, wherein the method comprises the step of using a medium containing methyl-cellulose in the cultivation of white blood cells.

### Claim 13 (depends on 1)

A kit containing a medium containing methylcellulose and instructions for carrying out the method of claim 1.
